Skip to main content

Table 3 Comparisons among the three groups regarding clinical, laboratory findings and postoperative morbidities

From: Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study

Variable

Groups

P. V. (Sig.)

Group (A)

(n = 38)

Group (B)

(n = 48)

Group (C)

(n = 16)

Pre op. Hb (g/dl)

11.3 ± 0.3

11.4 ± 0.7

11.4 ± 0.4

0.665NS

Post op. Hb (g/dl)

9.5 ± 0.4

9.7 ± 0.5

10.7 ± 0.5

0.047*

Decrease in Hb (%)

15.7 ± 3.8

14.9 ± 4.1

8.6 ± 2.7

0.036*

Estimated blood loss (L)

2.84a ± 1.12

2.58 b ± 1.03

2.12 c ± 0.87

0.048

Blood transfusion (units)

3.8a ± 1.2

3.7 a ± 1.1

2.9 b ± 0.6

0.018*

Mean duration of hospital stay (days)

6.8 b ± 1.8

5.1c ± 1.8

8.4 a ± 1.4

< 0.00**

Hospital stay (day)

2

2 (5.3%)

4 (8.3%)

0

< 0.00**

3–5

4 (10.5%)

30 (62.5%)

0

6–7

14 (36.8%)

6 (12.5%)

8 (50%)

> 7

18 (47.4%)

8 (16.7%)

8 (50%)

CCComplications

No

10 (26.3%)

32 (66.7%)

9 (56.25%)

< 0.00**

Yes

Bladder injury

15 (39.5%)

4 (8.3%)

1 (6.25%)

1ry PPH

0

6 (12.5%)d

0

2ndry PPH

0

0

2 (12.5%)

ICU admission

8 (21.1%)

4 (8.3%)

1 (6.25%)

Coagulopathy

4 (10.5%)

2 (4.2%)

0

Infection

0

0

2 (12.5%)

 

Delayed hysterectomy

0

0

2 (12.5%)

 

Re-exploration

1 (2.6%)

0

0

 

Mortality

0

0

0

0

  1. NS Not significant, * = Significant (p < 0.05), ** = highly significant (p < 0.01), HB Haemoglobin, PPH Postpartum haemorrhage, ICU Intensive care unit, a, b, c,Means with different superscript in the same raw are significantly different
  2. din group B, six cases developed primary PPH after the primary procedure (cervical tamponade), four of them had hysterectomy and the remaining 2 cases were managed conservatively by insertion of intrauterine Bakri balloon